Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Novel biomarkers in Alzheimer’s disease using high resolution proteomics and metabolomics: miRNAS, proteins and metabolites

2 Nov 2020

Abstract excerpt

Alzheimer's disease (AD) is the most common form of dementia. It affects approximately 6% of people over the age of 65 years. It is a clinicopathological, degenerative, chronical and progressive disease that exhibits a deterioration of memory, orientation, speech and other functions. Factors contributing to the pathogenesis of the disease are the presence of extracellular amyloid deposits, called neuritic senile...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Alzheimer's disease research and treatments
Share to Metabolomics and Mass Spectrometry Studies
Share to Tryptophan and brain disorders

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Source

Identifiers

PMID: 33137264
DOI: 10.1080/10408363.2020.1833298

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 19 Oct 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Novel biomarkers in Alzheimer’s disease using high resolution proteomics and metabolomics: miRNAS, proteins and metabolitesPMID 33137264Read ↗

Proteomic Insight Into Alzheimer's Disease Pathogenesis PathwaysSemantic proximity Read ↗

Amyloid Beta and MicroRNAs in Alzheimer’s DiseaseSemantic proximity Read ↗

Neurodegeneration and Alzheimer's disease (AD). What Can Proteomics Tell Us About the Alzheimer's Brain?Semantic proximity Read ↗

Next-generation biomarker discovery in Alzheimer's disease using metabolomics - from animal to human studies.Semantic proximity Read ↗

microRNA-Based Biomarkers in Alzheimer’s Disease (AD)Semantic proximity Read ↗

Potential Implications of miRNAs in the Pathogenesis, Diagnosis, and Therapeutics of Alzheimer’s DiseaseSemantic proximity Read ↗

Blood-Based Biomarkers in Alzheimer’s Disease: Advancing Non-Invasive Diagnostics and PrognosticsSemantic proximity Read ↗

Proteomic landscape of Alzheimer’s Disease: novel insights into pathogenesis and biomarker discoverySemantic proximity Read ↗

Advancements in multi-omics research to address challenges in Alzheimer’s disease: a systems biology approach utilizing molecular biomarkers and innovative strategiesSemantic proximity Read ↗

Large-scale proteomic analyses of incident Alzheimer’s disease reveal new pathophysiological insights and potential therapeutic targetsSemantic proximity Read ↗

miRNAs as Therapeutic Tools in Alzheimer’s DiseaseSemantic proximity Read ↗

Plasma microRNAs as potential biomarkers in early Alzheimer disease expressionSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.